|Last Update: 05/24/13 - 4:02 PM EDT|
|YTD Performance: 3.58%|
|Previous Close: $19.44|
|52 Week Range: $13.52 - $19.95|
|Oustanding Shares: 163,135,025|
|Market Cap: 3,150,234,718|
|Qtr (04/13)||Qtr (07/13)||FY (01/14)||FY (01/15)|
|Number of Analysts||11||10||13||10|
|Growth Rate (Year over Year)||12.22%||14.06%||13.20%||15.01%|
I outlined a few longs this morning, so it's only fair to look at the flip side of the coin.
When searching for new potential short plays this is one of the first sectors I hit.
CHS was downgraded from Outperform to Market Perform, FBR Capital Markets said. $18 price target. Valuation call, as the stock is up 68% year-to-date.
Contributor Ken Shreve takes a look at upcoming economic data and some key earnings reports for the week of Nov. 19
CHS estimates were raised through 2014, UBS said. Higher sales are driving margin expansion.
Contributor Ken Shreve takes a look at economic data and earnings reports scheduled for the coming week.
These two companies, which deal in women’s products, are worth a closer look.
CHS was upgraded from Neutral to Overweight, Piper Jaffray said. $22 price target. Industry is poised for a multi-year recovery cycle.
CHS was downgraded from Equal-weight to Underweight, Morgan Stanley said. $13.50 price target. Store checks show increased discounting.
CHS estimates updated through 2012, Oppenheimer said. Expect positive trends to continue. Perform rating.